EntryPoint Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
EntryPoint Capital's EW Position: Q1 2026 in Review
EntryPoint Capital reduced its Edwards Lifesciences (EW) stake by 47% in Q1 2026, selling an estimated $202K and leaving 2,761 shares worth $221K. The position accounts for 0.06% of the portfolio, ranked #602.
EntryPoint Capital first reported a position in EW in Q4 2023 and has held it in 5 quarters since. The position peaked at $686K in Q3 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- EntryPoint Capital held 2,761 shares of Edwards Lifesciences worth $221K as of Q1 2026.
- EntryPoint Capital sold 2,456 Edwards Lifesciences shares in Q1 2026, an estimated $202K.
- Edwards Lifesciences made up 0.06% of EntryPoint Capital's portfolio in Q1 2026, its #602 holding.
- EntryPoint Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 5 quarters since.
- EntryPoint Capital's Edwards Lifesciences position peaked at $686K in Q3 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.